, opens new tab said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer (PFE.N) , opens new ...
Though Covid sales have dropped, the market for mRNA vaccines is expected to grow to around $40bn by 2033, according to data published by Precedence Research. The EPO verdict on Moderna’s patent win ...
Bangalore, 17. Mai (Reuters) - Das US-Biotech-Unternehmen Moderna hat nach eigenen Angaben im Streit mit den Rivalen Pfizer und BioNTech um seinen Corona-Impfstoff einen Fall vor dem Europäischen ...
This is just one of several patent disputes brought by biotech companies. The EU Patent Office revoked a Moderna patent in November 2023. In the USA, Moderna filed a patent lawsuit against Pfizer ...
NEW YORK (Reuters) – Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key ...
Moderna said on May 17 that the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech.
(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine ...
17. Mai (Reuters) - Das US-Biotech-Unternehmen Moderna hat nach eigenen Angaben im Streit mit den Rivalen Pfizer und BioNTech um seinen Corona-Impfstoff einen Fall vor dem Europäischen Patentamt ...
London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and ...